IDEXX Laboratories (WBO:IDXX) 3-Year Revenue Growth Rate

: 11.80% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

IDEXX Laboratories's Revenue per Share for the three months ended in Dec. 2023 was €9.85.

During the past 12 months, IDEXX Laboratories's average Revenue per Share Growth Rate was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of IDEXX Laboratories was 35.60% per year. The lowest was 8.40% per year. And the median was 13.45% per year.

Competitive Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDEXX Laboratories 3-Year Revenue Growth Rate Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's 3-Year Revenue Growth Rate falls into.

IDEXX Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

IDEXX Laboratories (WBO:IDXX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

IDEXX Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (WBO:IDXX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (WBO:IDXX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany I1DX34:Brazil

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.